A Randomized, Placebo-Controlled, Parallel-Design, Exploratory Study to Evaluate the Efficacy of fremanezumab in Subjects with Rosacea

15/06/2021
14/03/2024
EU PAS number:
EUPAS41590
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information